The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open label, single arm, multicenter phase II study of the efficacy and safety of LP-168 monotherapy for relapsed or refractory mantle cell lymphoma.
 
Yuqin Song
No Relationships to Disclose
 
Xiaoqiong Tang
No Relationships to Disclose
 
Qingqing Cai
No Relationships to Disclose
 
Lihong Liu
No Relationships to Disclose
 
Hongmei Jing
No Relationships to Disclose
 
Ming Jiang
No Relationships to Disclose
 
Xiuhua Sun
No Relationships to Disclose
 
Jianqiu Wu
No Relationships to Disclose
 
Yu Yang
No Relationships to Disclose
 
Huijing Wu
No Relationships to Disclose
 
Zhigang Peng
No Relationships to Disclose
 
Kaiyang Ding
No Relationships to Disclose
 
Shuhua Yi
No Relationships to Disclose
 
Xiaojing Yan
No Relationships to Disclose
 
Guowu Wu
No Relationships to Disclose
 
Yudan Wu
No Relationships to Disclose
 
Jie Cui
No Relationships to Disclose
 
Pengju Ou
Employment - Guangzhou Lupeng Pharmaceutical
Leadership - Guangzhou Lupeng Pharmaceutical
Honoraria - Guangzhou Lupeng Pharmaceutical
 
Fenlai Tan
Employment - Guangzhou Lupeng Pharmaceutical
Leadership - Guangzhou Lupeng Pharmaceutical
Stock and Other Ownership Interests - Guangzhou Lupeng Pharmaceutical
Honoraria - Guangzhou Lupeng Pharmaceutical
 
Jun Zhu
No Relationships to Disclose